Amylyx Pharmaの空売り状況は、投資家がAmylyx Pharmaの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Amylyx Pharma (NASDAQ:AMLX) 株価情報, 空売り情報

Amylyx Pharma

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals Inc

News

Guidance

Spirit AeroSystems Expects Continued Operational Environment And Higher Delivery Rates To Drive Better Results In 2025

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Buy and lowers the price target from $80 to $75.

Price Target

Reiteration

Analyst Ratings

CRBP

HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Lowers Price Target to $75

Canaccord Genuity analyst Brian McNamara maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Buy and lowers the price target from $15 to $14.

Canaccord Genuity Maintains Buy on Newell Brands, Lowers Price Target to $14

Revenue decreased from the fourth quarter of 2023, primarily due to the impacts from the Boeing Memorandum of Agreement (MOA) executed in October&nbsp;2023 recognized in the fourth quarter of 2023, including favorable pricing adjustments on the Boeing 787 program and the reversal of the potential claim related to the Boeing 737 vertical fin attach fittings issue, partially offset by higher Defense and Space revenues in the fourth quarter of 2024.&nbsp;
Overall deliveries increased during the fourth quarter of 2024 compared to the same period of 2023, including higher Boeing 737 deliveries.
Gross loss was recognized in the fourth quarter of 2024 compared to gross profit for the same period of 2023. The operating income recognized in the fourth quarter of 2023 included the favorable impact of the Boeing MOA executed in October&nbsp;2023 to the Boeing 787 program, including favorable change in estimates as well as a material right obligation liability reversal.

Spirit AeroSystems Says Merger With Boeing On Track To Close In Mid-2025

Spirit AeroSystems Q4 Preliminary Net Revenues $1.662B Vs $1.813B Last Year; Est $1.614B

HC Wainwright &amp; Co. analyst Ed Arce downgrades Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) from Buy to Neutral.

Downgrades

PLRX

HC Wainwright & Co. Downgrades Pliant Therapeutics to Neutral

Bozeman has served as President and Chief Executive Officer, and a director, of C.H. Robinson since 2023.&nbsp;

Management

3M Adds David Bozeman To Board, Amy Hood Does Not Intend To Stand For Reelection

Michael F. Roman, Executive Chairman of the Board of Directors, has announced his intention to retire as Executive Chairman, and as a Director, effective March 1, 2025.&nbsp; Mr. Roman has agreed to continue to serve as Executive Advisor to the Board until his retirement from 3M on May 1, 2025.&nbsp;

3M Names William Brown, Its CEO And Director, To Serve As Its Chairman, Effective March 1, 2025 In Addition To His Current Responsibilities

SPACE

Contracts

General

GSAT

MDA Space Has Signed A Definitive Contract With Globalstar To Be The Prime Contractor For The Satellite Operator's Next-Generation Low Earth Orbit Constellation, With A Total Contract Value Of Approximately $1.1B

Ancora Issues Letter To US Steel's Board; Says Independent Slate and Alan Kestenbaum Are Ready to Lead Multibillion-Dollar Capital Investment Program to Revitalize Company

TRX Gold Secures New Financing Agreements With Stanbic And Auramet To Boost Liquidity, Expand Growth Opportunities

Needham analyst Mike Cikos reiterates Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) from Hold to Hold.

Needham Reiterates Hold on Dynatraceto Hold

President Donald Trump announced on Sunday that he will impose new 25% <a href="https://www.benzinga.com/markets/equities/25/02/43583123/trump-to-announce-25-steel-and-aluminum-tariffs-economist-warns-president-is-making-us-manufacturing-globally-uncompetitive">tariffs</a> on all steel and aluminum imports, adding to existing duties, in a further escalation of his trade policy. While this could impact domestic steel and aluminum companies, investors can consider the following list of exchange-traded funds (ETFs) to trade following the development.
What Happened: On his way to the NFL Super Bowl in New Orleans, Trump spoke to reporters on Air Force One, and said he would reveal the <a href="https://www.benzinga.com/markets/equities/25/02/43583123/trump-to-announce-25-steel-and-aluminum-tariffs-economist-warns-president-is-making-us-manufacturing-globally-uncompetitive">new tariffs</a> on Monday, followed by reciprocal tariffs on Tuesday or Wednesday, matching the rates imposed by other countries.
Tariffs impact domestic companies by influencing costs, competitiveness, and supply chains
According to a report by the First National Bank of Omaha and the think tank Council on Foreign Relations, the negative effects of tariffs include increased input costs, reduced competitiveness, disruption in supply chains, retaliation, diversion in investment, and reduced consumer spending. On the positive side, tariffs may temporarily protect domestic industries and generate government revenue.
Investors should look out for the following metal ETFs as Trump is likely to impose tariffs on imports.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Fund Name</td>
<td>AUM</td>
<td>Expense Ratio</td>
<td>Six Month Returns</td>
</tr>
<tr>
<td>VanEck Steel ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLX#NYSE">SLX</a>)</td>
<td>$75.23 million</td>
<td>0.56%</td>
<td>-4.88%</td>
</tr>
<tr>
<td>Invesco DB Base Metals Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBB#NYSE">DBB</a>)</td>
<td>$112.4 million</td>
<td>0.79%</td>
<td>2.39%</td>
</tr>
<tr>
<td>iShares U.S. Basic Materials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYM#NYSE">IYM</a>)</td>
<td>$534.51 million</td>
<td>0.39%</td>
<td>-0.68%</td>
</tr>
<tr>
<td>SPDR S&amp;P Metals and Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>)</td>
<td>$1623.5 million</td>
<td>0.35%</td>
<td>5.00%</td>
</tr>
</tbody>
</table>
</figure>
Iron ore, a key ingredient in steelmaking, saw its prices rise 0.71% in Singapore around 3:43 p.m. local time, while aluminum futures on the Comex gained 0.49%.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43583123/trump-to-announce-25-steel-and-aluminum-tariffs-economist-warns-president-is-making-us-manufacturing-globally-uncompetitive">Trump To Announce 25% Steel And Aluminum Tariffs — Economist Warns President Is &#8216;Making US Manufacturing Globally Uncompetitive&#8217;</a> 
Why It Matters: Although Trump initially paused tariffs on Canada and Mexico, he has renewed threats by specifically targeting metals in his media interactions on Sunday.
According to the American Iron and Steel Institute&#8217;s January <a href="https://www.steel.org/2025/02/aisi-releases-january-sima-imports-data-4/">data</a>, the U.S. gets most of its imported steel from Canada, Brazil, and Mexico, followed by South Korea and Vietnam. 
&#8220;Canadian steel and aluminum support key industries in the U.S., from defence, shipbuilding, and auto,&#8221; said the Canadian Minister of Innovation, Science and Industry, Francois-Philippe Champagne, in an X post.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Let's all be clear. Canadian steel and aluminum support key industries in the U.S. from defence, shipbuilding and auto. This is making North America more competitive and secure. We will continue to stand up for Canada, our workers, and our industries. <a href="https://t.co/NBFeU6Y8zN">pic.twitter.com/NBFeU6Y8zN</a>
&mdash; François-Philippe Champagne (FPC) &#x1f1e8;&#x1f1e6; (@FP_Champagne) <a href="https://twitter.com/FP_Champagne/status/1888754195727106310?ref_src=twsrc%5Etfw">February 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Citing the risks of these metal tariffs, Joseph Brusuelas, the principal and chief economist at RSM US said that other countries could follow to protect their economies, and a much larger trade war could ensue after these impositions by Trump.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">US-China Trade War: With Trump set to announce 25% tariffs on aluminum &amp; steel imports and the Chinese imposing $14 billion on trade taxes on U.S. good it is likely that a series of tit-for-tat retaliation has begun. A look at relative yield differentials between the US and… <a href="https://t.co/ACWRKgzlmg">pic.twitter.com/ACWRKgzlmg</a>
&mdash; Joseph Brusuelas (@joebrusuelas) <a href="https://twitter.com/joebrusuelas/status/1888728283392667924?ref_src=twsrc%5Etfw">February 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/02/43521806/deepseeks-hedge-fund-owner-had-multiple-top-projects-before-creating-the-firm-that-fueled-1-trillion-market-cap-erosion-of-ai-stocks">DeepSeek&#8217;s Hedge Fund Owner Had Multiple Top Projects Before Creating The Firm That Fueled $1 Trillion Market Cap Erosion Of AI Stocks</a></li>
</ul>
Photo courtesy: Shutterstock

Government

Politics

Economics

Markets

ETFs

iShares Trust Dow Jones US Basic Materials Sector Index Fund

Donald Trump's Expected Tariffs On Aluminum, Steel Imports May Impact Domestic Companies: Here's A List Of Metal ETFs That Could Be Affected

Raymond James analyst John Freeman downgrades ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) from Strong Buy to Outperform and lowers the price target from $157 to $124.

Raymond James Downgrades ConocoPhillips to Outperform, Lowers Price Target to $124

HC Wainwright &amp; Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) with a Buy and raises the price target from $11 to $12.

SRTS

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $12

On Friday, February 7, U.S. markets closed lower after Trump announced plans for reciprocal tariffs amid weak jobs data and declining consumer sentiment. Despite early struggles, strong earnings provided some support. Consumer sentiment hit a seven-month low, inflation expectations surged, and job growth slowed, reinforcing expectations that the Fed will delay rate cuts until June.
The University of Michigan reported a sharp rise in inflation expectations, with the one-year outlook hitting 4.3%, the highest since November 2023. February&#8217;s jobs report showed mixed results: job growth slowed, but unemployment dropped more than expected, and wages surged.
All S&amp;P 500 sectors ended in the red, led by losses in communication services, consumer discretionary, and materials stocks.
The Dow Jones Industrial Average was down 0.99% and closed at 44,303.40, the S&amp;P 500 closed lower by 0.95% at 6,025.99, and the Nasdaq Composite fell 1.36% to finish at 19,523.40.
Aisa Markets Today
<ul>
<li>On Monday, Japan&#8217;s Nikkei 225 closed lower by 0.12% at 38,770.50, led by losses in the Glass, Retail and Real Estate sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 declined 0.34% to 8,482.80, led by losses in the IT, Telecoms Services and Materials sectors.</li>
<li>India&#8217;s Nifty 50 closed lower by 0.78% at 23,376.05, and Nifty 500 slid 1.32%, closing at 21,360.55, led by losses in the Real Estate, Metals, and Consumer Durables sectors.</li>
<li>China&#8217;s Shanghai Composite rose 0.56% and closed at 3,322.17, and Shanghai Shenzhen CSI 300 was up 0.21% at 3,901.06.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session higher by 1.84% at 21,521.98.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was up 0.37%.</li>
<li>Germany&#8217;s DAX rose 0.31%.</li>
<li>France&#8217;s CAC gained 0.26%.</li>
<li>U.K.&#8217;s FTSE index 100 traded higher by 0.47%</li>
<li>European stocks opened higher on Monday despite Trump&#8217;s new tariff announcement. Markets remain optimistic amid strong earnings growth, cheap valuations, and hopes for ECB easing. Nokia appointed Justin Hotard as its new CEO.</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.17% at $71.81/bbl, and Brent was up 1.15% at $75.50/bbl.</li>
<li>Oil prices rose, rebounding from last week&#8217;s losses amid trade war concerns. Sanctions on Russia and Iran add upside risks, but analysts expect oil to trade lower, with Brent forecasted at $60-$65 per barrel in late 2025.</li>
<li>Natural Gas gained 3.35% to $3.420.</li>
<li>Gold was trading higher by 1.46% at $2,930.21, Silver was up 0.95% to $32.750, and Copper rose 0.69% to $4.6200.</li>
<li>Gold hit record highs as Trump&#8217;s new tariffs fueled safe-haven demand. Markets remain cautious over potential trade war escalation, while strong U.S. inflation data and high interest rates could limit further gold gains.</li>
</ul>
U.S. Futures at 05:30 AM ET
<ul>
<li>Dow futures were up 0.28%, S&amp;P 500 futures gained 0.40%, and Nasdaq 100 futures rose 0.62%.</li>
<li>U.S. stock futures rose, led by steelmakers after Trump announced new tariffs. Investors remain cautious but less reactive to trade moves.</li>
</ul>
Forex at 05:30 AM ET
The U.S. Dollar Index gained 0.10% to 108.15, USD/JPY was up 0.52% to 152.19, and USD/AUD fell 0.14% to 1.5921.
Image via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Advances, Gold Hits Record High On Safe-Haven Demand - Global Markets Today While US Slept

Needham analyst Mike Cikos reiterates Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Buy and maintains $50 price target.

TENB

Needham Reiterates Buy on Tenable Holdings, Maintains $50 Price Target

Jones Trading analyst Jason Weaver maintains Alpine Income Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>) with a Buy and maintains $22 price target.

PINE

Jones Trading Maintains Buy on Alpine Income Prop Trust, Maintains $22 Price Target

B of A Securities analyst John Murphy upgrades Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) from Underperform to Neutral and raises the price target from $12 to $19.

Upgrades

MBLY

B of A Securities Upgrades Mobileye Global to Neutral, Raises Price Target to $19

Needham analyst Matt Dezort reiterates Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) from Hold to Hold.

QLYS

Needham Reiterates Hold on Qualysto Hold

Amylyx (AMLX) announced the design of its pivotal Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class glucagon-like p...

Amylyx announces design of LUCIDITY clinical trial

Amylyx Pharmaceuticals Inc ( ($AMLX) ) has provided an update. Amylyx Pharmaceuticals Inc. has entered into a collaboration with Gubra A/S to devel...

Amylyx Partners with Gubra for GLP-1 Antagonist

Gubra A/S announced a collaboration with Amylyx (AMLX) Pharmaceuticals for the development of a potential novel long-acting GLP-1 receptor antagoni...

Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development

Amylyx (AMLX) Pharmaceuticals announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company's Leader...

Amylyx appoints Dan Monahan as Chief Commercial Officer

Amylyx Pharmaceuticals down 3%, announces stock offering

NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration

Amylyx (AMLX) Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to use ...

Amylyx announces common stock offering, no amount given

Amylyx stock dips after pricing $60M stock offering

FDA lifts clinical hold on Amylyx ALS drug study

New insider activity at Amylyx Pharmaceuticals Inc ( ($AMLX) ) has taken place on February 6, 2025. Recent transactions at Amylyx Pharmaceuticals I...

Amylyx Pharmaceuticals Executives Cash In on Stock Sales

ABBV

ALEC

AMLX

BIIB

COYA

DNLI

HLBBF

HLUBF

INMB

LCTX

MTLHF

MTLHY

NGENF

RHHBF

RHHBY

RHHVF

SRPT

STOK

Press Releases

Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome

Comments

Amylyx Pharma

空売り

Amylyx Pharma (NASDAQ:AMLX) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル